AI-generated summary
In a small randomized pilot trial of women with breast cancer receiving chemotherapy, the authors compared bright blue-green light with dim red light, both self-administered at home for 21 days. The authors report that the bright light group had shorter sleep latency, longer total sleep time, and lower depression scores than controls, and they describe these findings as suggesting likely benefit. Features such as timing and duration require further study.
- Who or what was studied
- Women with stage I-III breast cancer undergoing chemotherapy
- Limits stated in the abstract
- The authors describe this as a pilot study, and the abstract states that treatment duration, frequency, and timing require further investigation.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Depression, Pilot study, Lux, Randomized controlled trial. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.